Kalaris Therapeutics, Inc. (KLRS) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$43.44M | +37.2% |
| 2024 | -$69.17M | +63.7% |
| 2023 | -$190.42M | -12.9% |
| 2022 | -$168.71M | +1.9% |
| 2021 | -$171.96M | -146.4% |
| 2020 | -$69.78M | -192.7% |
| 2019 | -$23.84M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$43.44M | +37.2% |
| 2024 | -$69.17M | +63.7% |
| 2023 | -$190.42M | -12.9% |
| 2022 | -$168.71M | +1.9% |
| 2021 | -$171.96M | -146.4% |
| 2020 | -$69.78M | -192.7% |
| 2019 | -$23.84M | — |